These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23161837)

  • 1. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.
    Knauer SK; Unruhe B; Karczewski S; Hecht R; Fetz V; Bier C; Friedl S; Wollenberg B; Pries R; Habtemichael N; Heinrich UR; Stauber RH
    Hum Mutat; 2013 Feb; 34(2):395-404. PubMed ID: 23161837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
    Engels K; Knauer SK; Metzler D; Simf C; Struschka O; Bier C; Mann W; Kovács AF; Stauber RH
    J Pathol; 2007 Apr; 211(5):532-540. PubMed ID: 17334981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal.
    Stauber RH; Rabenhorst U; Rekik A; Engels K; Bier C; Knauer SK
    Traffic; 2006 Nov; 7(11):1461-72. PubMed ID: 16984408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear export is essential for the tumor-promoting activity of survivin.
    Knauer SK; Krämer OH; Knösel T; Engels K; Rödel F; Kovács AF; Dietmaier W; Klein-Hitpass L; Habtemichael N; Schweitzer A; Brieger J; Rödel C; Mann W; Petersen I; Heinzel T; Stauber RH
    FASEB J; 2007 Jan; 21(1):207-16. PubMed ID: 17099069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin's dual role: an export's view.
    Knauer SK; Mann W; Stauber RH
    Cell Cycle; 2007 Mar; 6(5):518-21. PubMed ID: 17361097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin.
    Habtemichael N; Wünsch D; Bier C; Tillmann S; Unruhe B; Frauenknecht K; Heinrich UR; Mann WJ; Stauber RH; Knauer SK
    Gene; 2010 Dec; 469(1-2):9-17. PubMed ID: 20727954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential.
    Lippert BM; Knauer SK; Fetz V; Mann W; Stauber RH
    Int J Cancer; 2007 Sep; 121(6):1169-74. PubMed ID: 17617794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homodimerization antagonizes nuclear export of survivin.
    Engelsma D; Rodriguez JA; Fish A; Giaccone G; Fornerod M
    Traffic; 2007 Nov; 8(11):1495-502. PubMed ID: 17714426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
    Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
    Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.
    Mandic R; Schamberger CJ; Müller JF; Geyer M; Zhu L; Carey TE; Grénman R; Dünne AA; Werner JA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6845-52. PubMed ID: 16203773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels.
    Kumar B; Yadav A; Lang JC; Cipolla MJ; Schmitt AC; Arradaza N; Teknos TN; Kumar P
    Mol Cancer Ther; 2012 Sep; 11(9):1988-98. PubMed ID: 22723337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.
    Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G
    Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Old Flame Never Dies: Survivin in Cancer and Cellular Senescence.
    Unruhe B; Schröder E; Wünsch D; Knauer SK
    Gerontology; 2016; 62(2):173-81. PubMed ID: 26159786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
    Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
    Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.
    Stauber RH; Mann W; Knauer SK
    Cancer Res; 2007 Jul; 67(13):5999-6002. PubMed ID: 17616652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2.
    Vischioni B; Giaccone G; Span SW; Kruyt FA; Rodriguez JA
    Exp Cell Res; 2004 Aug; 298(2):535-48. PubMed ID: 15265700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.